跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Oxari - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Oxari
Approved
STANDARD
Oxari
Admac Lifesciences
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c0d3fd2533c35604
Company
Admac Lifesciences
Type
Standard
Approval Details
Approval Id
c0d3fd2533c35604
Drug Approval Philippines Name
Oxari
Product Name
Oxari
Registration Number
DRP-8699-03
Brand Name
Oxari
Generic Name
Oxaliplatin
Dosage Form
Solution for Injection (IV)
Dosage Strength
2 mg / mL (50 mg / 25 mL)
Manufacturer
Admac Lifesciences
Importer
Pharmastar Int'l Trading Corp.
Distributor
Oncotine Pharmaceutical Products Distribution
Issuance Date
28 September 2024
Expiry Date
12 September 2028
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c0d3fd2533c35604
Type
Standard
Back to Philippines FDA Approvals